Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for AGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1996. Start Trial.
Date Value
December 31, 2025 2.998M
December 31, 2024 40.44M
December 31, 2023 76.11M
December 31, 2022 193.36M
December 31, 2021 306.92M
December 31, 2020 99.87M
December 31, 2019 61.81M
December 31, 2018 53.05M
December 31, 2017 60.19M
December 31, 2016 76.44M
December 31, 2015 171.67M
December 31, 2014 40.22M
December 31, 2013 27.35M
December 31, 2012 21.47M
December 31, 2011 10.75M
Date Value
December 31, 2010 19.78M
December 31, 2009 30.07M
December 31, 2008 34.46M
December 31, 2007 18.68M
December 31, 2006 40.10M
December 31, 2005 64.71M
December 31, 2004 89.79M
December 31, 2003 89.48M
December 31, 2002 58.72M
December 31, 2001 60.87M
December 31, 2000 99.14M
December 31, 1999 104.16M
December 31, 1998 22.17M
December 31, 1997 13.09M
December 31, 1996 9.588M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Novavax, Inc. 745.96M
Amgen, Inc. 9.129B
Anika Therapeutics, Inc. 57.48M
BioCryst Pharmaceuticals, Inc. 274.95M
Imunon, Inc. 8.781M